Research Article
Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for Lung Cancer Prognosis
Table 3
KEGG pathway enrichment results enriched by downstream targets of three TFs.
| Description | Gene ratio | BgRatio | value | FDR | value | Count |
| Circadian rhythm | 10/126 | 31/8101 | 1.94-11 | 4.71-09 | 3.93-09 | 10 | Allograft rejection | 5/126 | 38/8101 | 0.00028 | 0.033838 | 0.028259 | 5 | Oxytocin signaling pathway | 9/126 | 154/8101 | 0.000636 | 0.038062 | 0.031787 | 9 | Phosphatidylinositol signaling system | 7/126 | 97/8101 | 0.000751 | 0.038062 | 0.031787 | 7 | Transcriptional misregulation in cancer | 10/126 | 192/8101 | 0.000786 | 0.038062 | 0.031787 | 10 | FoxO signaling pathway | 8/126 | 131/8101 | 0.000959 | 0.038685 | 0.032308 | 8 | Neurotrophin signaling pathway | 7/126 | 119/8101 | 0.002472 | 0.065225 | 0.054472 | 7 | Longevity regulating pathway | 6/126 | 89/8101 | 0.002547 | 0.065225 | 0.054472 | 6 | Longevity regulating pathway—multiple species | 5/126 | 62/8101 | 0.002679 | 0.065225 | 0.054472 | 5 | Hypertrophic cardiomyopathy | 6/126 | 90/8101 | 0.002695 | 0.065225 | 0.054472 | 6 | Non-small cell lung cancer | 5/126 | 72/8101 | 0.005121 | 0.095997 | 0.080171 | 5 | Inositol phosphate metabolism | 5/126 | 73/8101 | 0.005431 | 0.095997 | 0.080171 | 5 | T cell receptor signaling pathway | 6/126 | 104/8101 | 0.00551 | 0.095997 | 0.080171 | 6 | Fluid shear stress and atherosclerosis | 7/126 | 139/8101 | 0.005836 | 0.095997 | 0.080171 | 7 | MAPK signaling pathway | 11/126 | 294/8101 | 0.00595 | 0.095997 | 0.080171 | 11 | Insulin resistance | 6/126 | 108/8101 | 0.006608 | 0.099953 | 0.083476 | 6 | AMPK signaling pathway | 6/126 | 120/8101 | 0.010857 | 0.154556 | 0.129077 | 6 | Asthma | 3/126 | 31/8101 | 0.012022 | 0.157127 | 0.131224 | 3 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 5/126 | 89/8101 | 0.012336 | 0.157127 | 0.131224 | 5 | GnRH signaling pathway | 5/126 | 93/8101 | 0.01471 | 0.164644 | 0.137502 | 5 | Rap1 signaling pathway | 8/126 | 210/8101 | 0.016473 | 0.164644 | 0.137502 | 8 | Circadian entrainment | 5/126 | 97/8101 | 0.017373 | 0.164644 | 0.137502 | 5 | Inflammatory mediator regulation of TRP channels | 5/126 | 98/8101 | 0.018086 | 0.164644 | 0.137502 | 5 | Inflammatory bowel disease | 4/126 | 65/8101 | 0.018212 | 0.164644 | 0.137502 | 4 | Lipid and atherosclerosis | 8/126 | 215/8101 | 0.018715 | 0.164644 | 0.137502 | 8 | Apoptosis | 6/126 | 136/8101 | 0.019138 | 0.164644 | 0.137502 | 6 | African trypanosomiasis | 3/126 | 37/8101 | 0.019429 | 0.164644 | 0.137502 | 3 | Insulin signaling pathway | 6/126 | 137/8101 | 0.019767 | 0.164644 | 0.137502 | 6 | Yersinia infection | 6/126 | 137/8101 | 0.019767 | 0.164644 | 0.137502 | 6 | Estrogen signaling pathway | 6/126 | 138/8101 | 0.02041 | 0.164644 | 0.137502 | 6 |
|
|